多替阿巴拉米片卖多少钱

It is currently the only three-in-one compound drug containing dolutegravir (DTG). It integrates therapeutic drugs for different stages of viral infection into the same tablet, one tablet at a time, and has the characteristics of high efficiency, good tolerance, high resistance barrier, and few drug interactions. So how much does it cost?

On January 22, 2018, dolutea palamid tablets were launched in China and are suitable for the treatment of adults and adolescents over 12 years old (with a weight of at least 40 kg) infected with human immunodeficiency virus (HIV). It is understood that the price of Dolutegra Abalamid tablets in India is about $900, and the specification is 30 tablets.

HIV-infected patients, regardless of race, should be screened for the HLA-B5701 allele before starting treatment with abacavir-containing products. If the patient is known to carry the HLA-B5701 allele, he should not take products containing abacavir.

Dolutea Abalamide Tablets are suitable for adults and adolescents over 12 years old and weighing not less than 40 kg. Since the ingredients in Dolute Abalamib Tablets may cause hypersensitivity reactions, regardless of the patient's race, before starting treatment with abacavir-containing products, they should be screened for HLA-B*5701 alleles.

The recommended dosage of dolutegra tablets is one tablet, once daily. Adults or adolescents whose weight is less than 40kg should not be given Trimax, because Dolutegra is a fixed-dose tablet and the dose cannot be reduced. Reducing the dose without authorization may result in ineffectiveness of the drug. Clinical data on dolutegravir tablets are limited, and the most commonly reported adverse reactions that may or may be related to dolutegravir and abacalongvir/lamivudine are nausea (12%), insomnia (7%), dizziness (6%), and headache (6%).

Very rarely, erythema multiforme, Stevens-Johnson syndrome, or toxic epidermal necrolysis may occur, and abacavir hypersensitivity cannot be excluded. In such cases, abacavir-containing medicinal products should be permanently discontinued. In individual patients, hypersensitivity reactions, including rash and severe hepatic effects, may occur. If patients experience mild side effects, don’t worry too much. They will generally subside over time. Once serious side effects occur, everyone must pay attention and seek medical treatment in time. Don’t be careless.

Recommended related hot articles: /newsDetail/85432.html